www.spokesman.com

www.spokesman.com
Share

www.spokesman.com

 •  September 8

The makers of the EpiPen failed to properly investigate more than 100 complaints that the device misfired during life-threatening emergencies — including situations in which patients later died, according to a Food and Drug Administration letter. In a warning letter, the FDA said Meridian Medical Technologies, a Pfizer company that manufactures the...

www.spokesman.com

 •  July 12

PHILADELPHIA – When doctors saw the report on Bill Ludwig’s bone-marrow biopsy, they thought it was a mistake and ordered the test repeated. But the results came back the same: His lethal leukemia had been wiped out by an experimental treatment never used in humans. “We were hoping for a little improvement,” remembers the 72-year-old retired New...

www.spokesman.com

 •  May 10

CHICAGO – Almost one-third of new drugs approved by U.S. regulators over a decade ended up years later with warnings about unexpected, sometimes life-threatening side effects or complications, a new analysis found. The results covered all 222 prescription drugs approved by the U.S. Food and Drug Administration from 2001 through 2010. The...

www.spokesman.com

 •  February 14

The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits. The investments come as researchers harness recent scientific advances, including the mapping of the...